January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 05, 2026
According to forecasts, the medical clothing market was valued at USD 122.74 billion in 2025 and is projected to grow from USD 130.65 billion in 2026 to USD 229.31 billion by 2035, registering a CAGR of 6.45% during the forecast period....
January 05, 2026
Projections indicate that, the macrolide antibiotics market was valued at USD 6.24 billion in 2025 and is projected to grow from USD 6.48 billion in 2026 to USD 9.18 billion by 2035, registering a CAGR of 3.94% during the forecast period. This report provides comprehensive coverage of market size, historical and forecast data, segmentation by drug ...
January 05, 2026
Based on market forecasts, the collagen fillers market was valued at USD 53.22 million in 2025 and is projected to grow from USD 56.65 million in 2026 to USD 99.34 million by 2035, registering a CAGR of 6.44% during the forecast period. The report provides in-depth coverage of market size, segment-wise analysis, regional performance across North Am...
January 05, 2026
Market insights predict, the fluoroquinolones market was valued at USD 4.89 billion in 2025 and is expected to reach USD 5.15 billion in 2026, expanding further to USD 8.16 billion by 2035 at a CAGR of 5.25%. The report provides detailed insights across key segments including molecule, route of administration, therapeutic indication, end-user, drug...
January 02, 2026
Projections indicate that, the global plasmid DNA manufacturing market will increase from USD 2.61 billion in 2025 to USD 14.59 billion by 2035, experiencing a CAGR of 18.77% over the next 10 years. Plasmid DNA is highly valuable in conducting research, studying diseases, studying gene mutations, repairing genetic material, and developing GMOs for ...
January 02, 2026
Market insights predict the global parenteral antibiotics industry will increase from USD 25.3 billion in 2025 to USD 38.7 billion by 2035, achieving a CAGR of 4.34%. The huge preference for parenteral antibiotics is driven by malabsorption issues, lack of oral formulations, and failed oral therapy....
January 02, 2026
According to market projections, the standard pen needle sector is expected to grow from USD 1.71 billion in 2025 to USD 3.31 billion by 2035, reflecting a CAGR of 6.84%. The increasing prevalence of type 1 diabetes and advances in medical technologies drive the global market. North America dominated the global market due to a robust healthcare inf...
January 02, 2026
Market insights predict, the U.S. Tuberculosis (TB) Diagnostics Market was valued at USD 650.8 million in 2025 and is projected to reach USD 687.51 million in 2026, further expanding to USD 1,126.5 million by 2035 at a CAGR of 5.64% (2026–2035). This report provides in-depth coverage of market size, growth trends, test type, disease type...
January 02, 2026
According to market projections, the respiratory infections antibiotics market was valued at USD 10.83 billion in 2026 and is projected to reach USD 17.01 billion by 2035, growing at a CAGR of 5.14%. The report delivers in-depth analysis across antibiotic class, route of administration, indication, healthcare setting, and regions including North Am...
December 31, 2025
The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a conven...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com